| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population
|
Lin Y.-C.;Hour T.-C.;Yu-Chieh Tsai;Huang S.-P.;Wu W.-J.;Chen C.-H.;Pu Y.-S.;Chung S.-D.;Huang C.-Y.; Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI; Huang S.-P.; Wu W.-J.; Chen C.-H.; Pu Y.-S.; Chung S.-D.; Huang C.-Y. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma
|
Guo J.-C.;Yu-Chieh Tsai;Pu Y.-S.; Guo J.-C.; YU-CHIEH TSAI; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:53Z |
Current and future aspect of immunotherapy for advanced renal cell carcinoma
|
Hsueh F.-J.;Yu-Chieh Tsai; Hsueh F.-J.; YU-CHIEH TSAI |
| 臺大學術典藏 |
2021-03-04T02:35:53Z |
Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer
|
Wang C.-C.;Yu-Chieh Tsai;Jeng Y.-M.; Wang C.-C.; YU-CHIEH TSAI; Jeng Y.-M. |
| 臺大學術典藏 |
2021-03-04T02:35:52Z |
Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion
|
Chen J.;Sun Y.;Ou Z.;Yeh S.;Huang C.-P.;You B.;Yu-Chieh Tsai;Sheu T.-J.;Zu X.;Chang C.; Chen J.; Sun Y.; Ou Z.; Yeh S.; Huang C.-P.; You B.; YU-CHIEH TSAI; Sheu T.-J.; Zu X.; Chang C. |
| 臺大學術典藏 |
2021-03-04T02:35:52Z |
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
|
Tien Y.;Tsai C.-L.;Hou W.-H.;Chiang Y.;Hsu F.-M.;Yu-Chieh Tsai;Cheng J.C.-H.; Tien Y.; Tsai C.-L.; Hou W.-H.; Chiang Y.; Hsu F.-M.; YU-CHIEH TSAI; Cheng J.C.-H. |
| 臺大學術典藏 |
2021 |
Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
|
Tsai M.-C.; Hu T.-H.; Hsiao C.-C.; Chuang C.-H.; Cho W.-R.; Huang P.-Y.; Chen D.-W.; Yong C.-C.; Wu Y.-J.; Liu Y.-W.; Sou F.-M.; YU-CHIEH TSAI |
